Sleep Aids in Venezuela
Sleep aids are negatively affected by the streamlining of multinational players. The supply of brands shrinks as companies focus on their best-selling products. Venezuelans are seeking sleep aid products as substitutes for increasingly scarce prescription drugs, such as anxiolytics. According to trade press, anxiety about the future, worries and concerns about shortages, personal security and even hunger are causing insomnia in approximately 15% of the adult population.
Euromonitor International's Sleep Aids in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Sleep Aids in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Sleep Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Prospects
Fewer Brands Available As Companies Focus on Best-selling Products
Restricted Budgets Impact Volume Sales
Herbal Products Perceived To Be Natural Solutions
Competitive Landscape
Domestic Companies Dominate
Small Category With Consistent Brand Positioning and Marketing
Increasing Popularity of Private Label
Category Data
Table 1 Sales of Sleep Aids: Value 2012-2017
Table 2 Sales of Sleep Aids: % Value Growth 2012-2017
Table 3 NBO Company Shares of Sleep Aids: % Value 2013-2017
Table 4 LBN Brand Shares of Sleep Aids: % Value 2014-2017
Table 5 Forecast Sales of Sleep Aids: Value 2017-2022
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2017-2022
Executive Summary
Shortages of Medicines Approach Humanitarian Crisis Levels
Negative Growth Rates Continue To Limit Supply in 2017
Multinational Players Are Largely Absent in 2017
Drugstores/parapharmacies Lead Retail Distribution
Future Performance Hinges on Macroeconomic and Industrial Policies
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017
Market Data
Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Distribution of Consumer Health by Format: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format and Category: % Value 2017
Table 15 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
Prospects
Fewer Brands Available As Companies Focus on Best-selling Products
Restricted Budgets Impact Volume Sales
Herbal Products Perceived To Be Natural Solutions
Competitive Landscape
Domestic Companies Dominate
Small Category With Consistent Brand Positioning and Marketing
Increasing Popularity of Private Label
Category Data
Table 1 Sales of Sleep Aids: Value 2012-2017
Table 2 Sales of Sleep Aids: % Value Growth 2012-2017
Table 3 NBO Company Shares of Sleep Aids: % Value 2013-2017
Table 4 LBN Brand Shares of Sleep Aids: % Value 2014-2017
Table 5 Forecast Sales of Sleep Aids: Value 2017-2022
Table 6 Forecast Sales of Sleep Aids: % Value Growth 2017-2022
Executive Summary
Shortages of Medicines Approach Humanitarian Crisis Levels
Negative Growth Rates Continue To Limit Supply in 2017
Multinational Players Are Largely Absent in 2017
Drugstores/parapharmacies Lead Retail Distribution
Future Performance Hinges on Macroeconomic and Industrial Policies
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017
Market Data
Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Distribution of Consumer Health by Format: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format and Category: % Value 2017
Table 15 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
